CLYM
Climb Bio, Inc. Common Stock
CLYM
CLYM
76 hedge funds and large institutions have $63.4M invested in Climb Bio, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.
Holders
76
Holders Change
-4
Holders Change %
-5%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
23
Reduced
23
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citigroup
New York
|
$2.26M |
| 2 |
CF
2
Cantor Fitzgerald
New York
|
$2.44M |
| 3 |
AAA
3
Affinity Asset Advisors
New York
|
$1.83M |
| 4 |
TCM
4
Tang Capital Management
San Diego,
California
|
$1.22M |
| 5 |
PLC
5
Peapod Lane Capital
Bedford Hills,
New York
|
$676K |
